BSE filing, BSE: 505285. Summary written from the filing by ALFA Finder's alert engine.
More from Tulive Developers Ltd
All →Tulive Developers Open Offer
Tulive Developers Ltd is delisting via an open offer at ₹750/share. The exit window for residual shareholders runs until July 2, 2027.
Tulive Developers Q4 FY26 Results: Net Loss of ₹0.4 Cr, Loss Widens
Tulive Developers Ltd reported a net loss of ₹0.4 Cr for Q4 FY26.
- Key figure
- Net loss ₹0.4 Cr
Tulive Developers Other Announcement
Tulive Developers Limited filed its Annual Secretarial Compliance Report for the financial year 2025-26. The report details adherence to SEBI regulations and past observation compliance status.
Tulive Developers Board Meeting Date
Tulive Developers scheduled a board meeting for May 30, 2026. Directors will consider and approve audited financial results for the year ended March 2026.
Tulive Developers Promoter Buying (Off-Market)
Altis Properties Private Limited, a promoter group entity, acquired 2,08,190 equity shares (9.66% stake) of Tulive Developers Limited on April 23, 2026. The acquisition was conducted pursuant to the company's delisting process, increasing the promoter group's holding from 37.50% to 47.16%.
Tulive Developers Other Announcement
Tulive Developers Limited announced the successful outcome of its voluntary delisting offer. The reverse book-building process resulted in a discovered price of Rs. 750 per share, which was accepted by the acquirers. Post-offer, promoter shareholding reached 94.32%, exceeding the 90% threshold required for a successful delisting under SEBI regulations.
Other financial results announcements
All →Sudarshan Pharma Industries Q2 FY27 Results: Net Profit ₹8.1 Cr, Up 92.9% YoY
Sudarshan Pharma Industries Ltd reported revenue from operations of ₹217 Cr (+28.5% YoY) and net profit of ₹8.1 Cr (+92.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹8.1 Cr · +92.9% YoY
STL Networks Q2 FY27 Results: Net Loss of ₹16.1 Cr, Loss Narrows
STL Networks Ltd reported revenue from operations of ₹270.1 Cr (+17.0% YoY) and a net loss of ₹16.1 Cr for Q2 FY27.
- Key figure
- Net loss ₹16.1 Cr
RPG Life Sciences Q2 FY27 Results: Net Profit ₹28.2 Cr, Down 23.6% YoY
RPG Life Sciences Ltd reported revenue from operations of ₹211.6 Cr (+16.5% YoY) and net profit of ₹28.2 Cr (-23.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹28.2 Cr · -23.6% YoY
Alldigi Tech Q2 FY27 Results: Net Profit ₹26.6 Cr, Up 51.1% YoY
Alldigi Tech Ltd reported revenue from operations of ₹153.3 Cr (+4.0% YoY) and net profit of ₹26.6 Cr (+51.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹26.6 Cr · +51.1% YoY
Krishna Defence and Allied Industries Q2 FY27 Results: Net Profit ₹1,532 Cr, Up 71.8% YoY
Krishna Defence and Allied Industries Ltd reported revenue from operations of ₹7,529 Cr (+55.7% YoY) and net profit of ₹1,532 Cr (+71.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1,532 Cr · +71.8% YoY
Bandaram Pharma Packtech Q2 FY27 Results: Net Profit ₹0.2 Cr, Up 100.0% YoY
Bandaram Pharma Packtech reported audited standalone and consolidated results for the quarter and half-year ended 30.09.2026. Consolidated revenue from operations for the half-year was Rs 4,540.28 lakhs.
- Key figure
- Net profit ₹0.2 Cr · +100.0% YoY